- Report
- December 2024
- 581 Pages
Global
From €4499EUR$4,950USD£3,869GBP
- Report
- December 2024
- 403 Pages
Global
From €4499EUR$4,950USD£3,869GBP
- Report
- December 2021
- 377 Pages
Global
From €2897EUR$3,188USD£2,491GBP
€3409EUR$3,750USD£2,931GBP
- Report
- September 2024
- 118 Pages
Global
From €5408EUR$5,950USD£4,650GBP
- Report
- February 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- August 2025
- 234 Pages
Global
From €2272EUR$2,500USD£1,954GBP
- Report
- August 2025
- 250 Pages
Global
From €2272EUR$2,500USD£1,954GBP
- Report
- August 2025
- 191 Pages
Global
From €3222EUR$3,545USD£2,771GBP
€3580EUR$3,939USD£3,079GBP
- Report
- April 2025
- 175 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- April 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- February 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- March 2025
- 120 Pages
Global
From €5408EUR$5,950USD£4,650GBP
- Report
- March 2024
- 200 Pages
Global
From €3772EUR$4,150USD£3,243GBP
- Report
- December 2023
- 52 Pages
Global
From €4499EUR$4,950USD£3,869GBP
- Report
- December 2022
- 68 Pages
Global
- Report
- July 2025
- 233 Pages
Global
From €2272EUR$2,500USD£1,954GBP
- Report
- September 2025
- 139 Pages
Global
From €4227EUR$4,650USD£3,634GBP
- Report
- March 2025
- 154 Pages
Global
From €4227EUR$4,650USD£3,634GBP
- Report
- November 2024
- 111 Pages
Global
From €4227EUR$4,650USD£3,634GBP
- Report
- August 2024
- 100 Pages
Global
From €4227EUR$4,650USD£3,634GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more